baber/WOPTO huggingface dataset:
Patent MX-147474-A (MX)
Inventor: ROSENBERG DAVID J
IPC: B01D19/00
Filed: 1979-07-19
Abstract: A filter for intravenous liquid administration is provided having a filter housing; a filter chamber in the housing; an inlet member and an outlet member in the housing in fluid flow communication with the filter chamber; a filter in the filter chamber disposed across the line of fluid flow through the chamber from the inlet member to the outlet member so that all through flow must pass through the filter; and dividing the chamber into two portions, one upstream and one downstream of the filter; a vent in the housing in flow communication with the upstream portion of the filter chamber; and a liquid-impermeable gas-permeable porous member disposed across the line of flow through the vent, so that all vent flow must pass through the member, the member restricting such flow to gas to which it is permeable; the inlet member being shaped for attachment to a supply of liquid for intravenous administration; and the outlet member being shaped for attachment to an intravenous liquid administration apparatus.
Patent MX-158021-A (MX)
Inventor: TINNES BERNHARD
IPC: B22D11/16
Filed: 1982-05-31
Abstract: For a slide closure 10 attached to a pouring vessel 2 which has a movable slide part 14 disposed between a bottom plate 12 and a discharge part 16, there is, in addition to a cylinder piston unit 24 acting on the slide part, which unit is dominant by way of a servocontrol block 26 by regulating arrangement 32, a vibrator 36 which is controlled by an oscillator 34. The vibrator 36 is switched into the connection between the cylinder-piston unit 24 and the movable slide part 14, and is in a position to oscillatingly drive the latter both in its closing position as well as in other positions and, indeed, in the same direction as the cylinder piston unit. A position generator 44 starts the oscillator 34 forcibly in the closed position.
Patent MX-152416-A (MX)
Inventor: CAPRIO A RONALD
IPC: G06F12/06
Filed: 1983-02-09
Abstract: The present disclosure describes an interface circuit arrangement which per se includes: a means for being addressed in accordance with its physical location, a means to generate signals which identify the circuit being addressed; and means to generate signals which effect a diagnostic routine of the circuit being addressed. The present disclosure further describes means, which operate in conjunction with a data handling system, to assert a priority value assigned to the interchangeable interface circuit and which, based on that priority, determines which one of a number of interchangeable interface circuits will be permitted to control a common data path.
Patent NZ-211527-A (NZ)
Title: Filtration with filtrate flow rate control system; method and apparatus
Inventor: SCHOENDORFER D W
IPC: B01D61/22
Filed: 1985-03-21
Abstract: A process for filtration of matter from a liquid suspension through a membrane uses a rotor within a concentric shell rotating with a surface velocity which, together with the rotor-shell gap and suspension viscosity, establishes vigorous vortex cells about the rotor. At least one of the rotor and shell surfaces include a filter membrane. Tangential velocity components at the membrane surface constantly sweep the membrane surface to limit cell deposition tendencies while constantly replenishing the medium to be filtered. The vortex cells are established along the length of the membrane despite the constant extraction of filtrate and the resultant change in physical characteristics of the suspension.
Patent NZ-231252-A (NZ)
Title: Preparation of 3,5 dimethyl-4-methoxy-pyridine derivatives and intermediates
Inventor: BAUMANN KARL
IPC: C07D213/68
Filed: 1989-11-03
Abstract: Process for the preparation of compounds of the general formula I 
<IMAGE>
 in which X denotes the radicals OH or Cl, by catalytic hydrogenation of 3,5-dimethyl-4-methoxypyridine-2-carbonitrile, subsequent reaction of the resulting 3,5-dimethyl-4-methoxypyridine-2-methanamine to give 3,5-dimethyl-4-methoxypyridine-2-methanol and, if desired, chlorination to give 3,5-dimethyl-4-methoxy-2-chloromethylpyridine, and the novel intermediate 3,5-dimethyl-4-methoxypyridine- 2-methanamine.
Patent NZ-231350-A (NZ)
Title: Animal sticking apparatus for animal to be slaughtered
Inventor: RANKIN RUSSEL JAMES
IPC: A22B3/00
Filed: 1989-11-10
Abstract: PCT No. PCT/AU89/00508 Sec. 371 Date May 31, 1991 Sec. 102(e) Date May 31, 1991 PCT Filed Nov. 23, 1989 PCT Pub. No. WO90/05454 PCT Pub. Date May 31, 1990.An animal sticking apparatus for sticking an animal to be slaughtered comprises a sticking tool (10) having two rotary or oscillating cutting blades (16) and support means (21) mounting the sticking tool (10) for insertion and withdrawal movements. The cutting blades (16) perform a cutting operation upon insertion and advancement of the sticking tool (10) into the thoracic entrance of the chest cavity of the animal, the sticking (10) tool cutting tissues as it is advanced and enabling the stick wound to remain open upon withdrawal of the sticking tool to promote rapid exsanguination. The sticking tool (10) after insertion into the animal is pivoted about a remote axis (A) to sever blood vessels near to the animal heart ensuring massive and rapid blood flow. A pair of cutting blades (27) are operative to cut the hide of the animal to form a pre-cut (B) before insertion of the sticking tool (10), the blades (27) being movable apart to separate the hide at the pre-cut (B) so as to expose a substantially sterile surface into which the sticking tool (10) is inserted. The pre-cut blades (27) have cutting edges (29) forming an acute angle to the hide surface and cause a cutting action from the hide inside the surface to the outside for maintaining substantially sterile conditions on the inside of the hide pre-cut (B).
Patent NZ-246006-A (NZ)
Title: Method for producing a supermarket trolley using synthetic material
Inventor: PALY JEAN-LUC
IPC: B62B3/10
Filed: 1992-12-01
Abstract: A method for producing a trolley made of a synthetic material, particularly a supermarket trolley comprising a leg (43) and a basket (3), wherein at least two trolley portions (1, 3) are first moulded, then assembled. Each side wall (1, 3), which is provided with flanges (12, 13), and a leg segment (2, 3) linked to said side wall (1,3), are integrally moulded. Said side walls (1, 3) are then joined with connecting elements (23) which fit inside said flanges (12, 13).
Patent NZ-256390-A (NZ)
Title: Vitamin d analogues and pharmaceutical compositions
Inventor: HANSEN KAI
IPC: A61P43/00
Filed: 1993-09-27
Abstract: PCT No. PCT/DK93/00311 Sec. 371 Date Jan. 3, 1995 Sec. 102(e) Date Jan. 3, 1995 PCT Filed Sep. 27, 1993 PCT Pub. No. WO94/07842 PCT Pub. Date Apr. 14, 1994Compounds of formula    <IMAGE>  I  wherein Q is a -CH2-, -CH=CH- or -C=C-; U is a C1-C6 alkylene; R1 is hydrogen, a C1-C4 alkyl or YR' in which Y stands for the radicals -SO- or -SO2- and R' stands for a C1-C4 alkyl; R2 and R3 are independently hydrogen or C1-C4 alkyl, and additionally R2 and R3, when taken together with the starred carbon atom, may form a C3-C6 carbocyclic ring; Z is hydrogen or hydroxy; and derivatives thereof. The compounds show antiinflammatory and immunomodulating effects as well as strong activity in inducing differentiation and inhibiting undesirable proliferation of certain cells. The compounds are prepared by adding an anion R- to 1(S),1(R)-bis-(tert-butyldimethylsilyl-oxy)-9,10-secopregna-5(E),7(E),10(19)-triene-20-one and the resulting compound is alkylated or acylated with R1X1 where X1 is a leaving group followed by triplet-sensitized photoisomerization and deprotection to give the compound of formula I.
Patent NZ-312715-A (NZ)
Title: Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
Inventor: BIGG DENNIS
IPC: C07D487/04
Filed: 1996-06-21
Abstract: camptothecin analogue characterised in that the hydroxy lactone of the camptothecin is a 'beta'-hydroxy lactone or the corresponding 'beta'-hydroxyacid, resulting from the opening of said lactone, or a derivative of said 'beta'-hydroxyacid, or a pharmaceutically acceptable salt thereof, is disclosed. In particular, compounds of formulae (I)  is disclosed. Methods for preparing the compounds of formulae (I), pharmaceutical compositions containing said compound, and their use, particularly as topoisomerase inhibitors and antitumoral drugs, are also disclosed.
Patent NZ-324482-A (NZ)
Title: Process for the synthesis of omeprazole
Inventor: GUSTAVSSON ANDERS
IPC: C07D401/12
Filed: 1996-12-05
Abstract: A process for the manufacture of omeprazole (depicted above) from pyrmethyl alcohol via pyrmethyl chloride and pyrmetazole.  The process is characterised in that the whole reaction sequence is carried out without any isolation or purification of intermediates. Further that the reaction is carried out in a main solvent system common for the whole reaction sequence and inert to the reactants formed during the process and used in the process. The process according to the present invention may also include an additional purification step.
Patent NZ-332202-A (NZ)
Title: Razor blade assembly with three blades within a cartridge
Inventor: APPRILLE DOMENIC V
IPC: B26B21/00
Filed: 1997-03-04
Abstract: A razor blade assembly (10) for mounting on a handle via a pivotal connection, the assembly including a housing (12) that carries three blade members (18, 20, 22), each having leading edges (29), and has a guard portion (14), a cap structure (2), and arcuate bearing surfaces  below the blade carrying portion that pivotally engage shell bearing connections of the handle. The pivot axis of the razor blade assembly is located in a region defined by an imaginary boundary extending from the first leading edge to the second leading edge when both are in the unloaded position, extending upward and rearward from the second leading edge to a position slightly above the upper surface of the housing at a location in front of the third leading edge, extending along and slightly above the upper surface of the housing to a position in front of the first leading edge, extending downward and forward to a location within the guard portion (14) below and forward of the first leading edge, and extending from the location within the guard portion upward and rearward to the first leading edge. The pivot axis is advantageously located at the secondary blade member leading edge. In preferred embodiments the blade members are resiliently mounted, and at least two of the blade member leading edges have sharpened cutting edges. The housing is provided with a cam surface (54) engaged by a spring loaded cam follower on the razor handle, and the cam can be contoured to provide an at-rest position other than a position midway between the limit of forward and rearward arcuate travel (not shown).
Patent NZ-332960-A (NZ)
Title: tetrahydro-cyclopropan[c]benz[e]-indol-4-one and tetrahydro-cyclopropan[c]benzo[e]-indole derivatives and medicaments
Inventor: BOGER DALE L
IPC: C07D209/96
Filed: 1997-05-30
Abstract: A compound of formula I is claimed wherein: R1 is alkyl or a group of formula II R2 and R3 together with the carbons of the depicted vinylene group, form a group W that is an N-substituted pyrrolidine ring containing the vinylene group with the proviso that R4 and R5 are H or R2 is H and R3 is an N-substituted subgroup represented by formula III with the proviso that R4 and R5 are H or R2 is H and R3, R4 and R5 are independently H or OCH3. A pharmaceutical composition containing a compound of formula I useful as DNA alkylating agent is claimed.
Patent NZ-333978-A (NZ)
Title: Film-building agent for protecting teats and udders against infection after milking, comprising a film-forming component and disinfecting agents
Inventor: BRAGULLA SIEGFRIED
IPC: A01N47/44
Filed: 1997-07-21
Abstract: A film-building agent useful to protect against infections that contains a film-building element and one or several active disinfectant substances. The film-building agent is characterised in that it contains: (a) as a  film-building agent,10 to 100 g/l polyvinyl alcohol polymers or copolymers with a molar mass in a range from 18,000 to 200,000; (b) as an active disinfectant substance, 0.2 to 3 g/l iodine in the form of polyvinylpyrrolidone iodine and/or 5 to 50 g/l chlorhexidine; and (c) 2 to 50 g/l ether carboxylic acids of the general formula R-(OC2H4)n-OCH2-COOH, in which R stands for an alkyl radical with 4 to 10 C atoms and n for a number from 2 to 8. Preferably, the agent also contains thickeners and anionic or non-ionic surfactants. It is particularly suitable to protect the teats and udders of cows, ewes and goats after milking and forms a visible, mechanically resistant film.
Patent NZ-334347-A (NZ)
Title: Abrasive grinding wheel wherein the vitreous bond after firing comprises less than 1 percent lithium oxide
Inventor: SHELDON DAVID A
IPC: B24D3/18
Filed: 1997-10-01
Abstract: An abrasive grinding wheel comprises silicon carbide abrasive grain, about 5-21 volume percent hollow ceramic spheres, and a vitreous bond.  The vitreous bond after firing comprises, on a weight percentage basis, greater than about 50% SiO2, less than about 16% Al2O3, from about 0.05 to about 2.5% K2O, less than about 1.0% Li2O and from about 9 to about 16% B2O3.  The hollow ceramic spheres may comprise fused mullite and silicon dioxide and have a size of about 1 to 1000 microns.
Patent NZ-336069-A (NZ)
Title: Container connector having a spout with a cap, a vent and tube
Inventor: HO TSAN-FO
IPC: B65D47/06
Filed: 1999-06-01
Abstract: container connector comprises a vent through-hole 23, an outer thread 22 formed on a first end of the container connector and a guide pipe 24 extending from the container connector, communicating with vent hole 23.  A float ball 25 is connected to guide pipe 24 so that an end portion of guide pipe 24 passes through float ball 25.
Patent NZ-501592-A (NZ)
Title: Halogenated polysiloxane resin such as fluorinated acrylic polysilaxane resin compositions characterised by not requiring the use of inorganic halogen-containing acids (hydrofluoric acid)
Inventor: DHALIWAL PRITAM S
IPC: C08L83/04
Filed: 1998-05-21
Abstract: A halogenated polysiloxane resin composition prepared by combining at least one silicone intermediate selected from the group consisting of hydroxy- and alkoxy-functional silicone intermediates; with at least one silane selected from the group consisting of arylalkoxy silanes, alkylalkoxy silanes, halogenated silanes, and mixtures thereof; an organic halogen-containing ingredient having functional groups selected from the group consisting of hydroxy, amine, and carboxyl groups; a resin selected from the group consisting of hydroxy- and epoxy-functional resins; and at least one curing agent selected from the group consisting of tertiary amines, aminosilanes, organometallic compounds, acids, bases, and mixtures thereof. The silicone intermediate has the general formula shown; wherein each R10 and R11 group is independently selected from the group consisting of the hydroxy group, alkyl, aryl and alkoxy groups having up to six carbon atoms, where each R9 and R12 group is independently selected from the group consisting of hydrogen, and alkyl, and aryl groups having up to 12 carbon atoms, and where n is selected so that the weight average molecular weight of the silicone intermediate is in the range of from about 100 to 10,000. The halogenated resin composition avoids the use of potentially dangerous halogen acids whilst displaying equal or superior properties of chemical, corrosion, weather, heat and fire, and ultraviolet resistance.
Patent NZ-513750-A (NZ)
Title: Crystal modification C of 8-cyano-1-cyclopropyl-7- (1S,6S-2,8- diazabicyclo -[4.3.0] nonan-8-yl) -6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic
Inventor: RAST HUBERT
IPC: A61K31/4709
Filed: 2000-02-14
Abstract: 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-f luoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid (CCDC) of the crystal modification C, characterised in that it has an X-ray powder diffractogram with the following reflection signals (2 theta) of high and medium intensity: 5.7, 12.6, 15.5, 17.2, 20.2, 26.4, 27. CCDC of the modification C is used to prepared medicaments. Also described is the use of CCDC of the modification C for the treatment or prophylaxis of bacterial conditions in non-human animals.
Patent NZ-515953-A (NZ)
Title: Microreservoir system on the basis of polysiloxanes and ambiphilic solvents
Inventor: MULLER WALTER
IPC: A61K47/22
Filed: 2000-06-20
Abstract: A transdermal therapeutic system on the basis of polysiloxane which contains micro-reservoirs filled with an active substance and one ambiphilic solvent is disclosed, wherein a transdermal therapeutic system comprising an active substance impermeable backing layer, at least one polymer layer with micro-reservoirs present therein, and at least one active substance dissolved therein, and a protective layer for removal before use, which has a combination of following features: (a) the polymer fraction of the polymer layer consists at least 70% by weight, preferably at least 80% by weight, of soluble polysiloxanes; (b) The solvent for the active substance consists at least 50% by wt. preferably at least 80% by wt., of ambiphillic, especially dipolar organic solvent; and (c) the ambiphillic solvent is soluble in polysiloxane to the extent of not more than 20% by wt. and is miscible with water at least up to a weight ratio of 1:3.
Patent NZ-518380-A (NZ)
Title: A method for treating biofilm and other slime products with endo-beta-1,2-galactanase
Inventor: RATTO MARJAANA
IPC: C12P19/14
Filed: 2000-09-29
Abstract: A method for treating biofilm and other slime products comprising  degrading  microbial  polysaccharides  using  an enzyme  preparation  with more than  200  AU/ml  endo-â-1,2- galactanase.
Patent NZ-518422-A (NZ)
Title: Process for the synthesis of (3aS)-5,5-dioxo-2,3,3a,4-tetrahydro-1H-pyrrolo[2,1-c][1,2,4]benzothiadiazine
Inventor: FOUCHER ELSA
IPC: C07D513/04
Filed: 2002-04-17
Abstract: The industrial synthesis of formula (I) whereby 0.4 to 2 mmol of a compound of formula (II) is hydrogenated in the presence of the catalyst of formula (III), in a mixture of toluene and isopropanol, under hydrogen pressure of from 4 to 25 bar, at from 40° to 90°, and in the presence of a base such as potassium or sodium tert-butoxide dissolved in an alcoholic solvent in an amount of formula (I), to yield directly the compound of formula (I) having an enantiomeric excess of more than 80%.
Patent NZ-525629-A (NZ)
Title: Gaming device and method
Inventor: WEISS STEVEN A
IPC: A63F13/00
Filed: 2001-10-12
Abstract: A method of operating a gaming device that comprises: - (a) Receiving a wager to enable the gaming device; (b) Enabling a primary display; and (c) Displaying at least one outcome defined by first indicia and leading to a bonus event. The bonus event is defined by a randomly numbered playfield orientated in a row-and-column (RXC) matrix, randomly generated second indicia distinct from the first indicia appear as a cage containing plural second indicia and subsequently launching second indicia onto the playfield. A first comparison means to determine whether the randomly generated second indicia match any positions on the randomly numbered playfield and second comparison means to determine whether the matched positions on the randomly numbered playfield correspond to a winning outcome and awarding credits if a winning outcome is attained.
Patent NZ-525633-A (NZ)
Title: Enhanced selection of genetically modified pine embryogenic tissue
Inventor: CONNETT-PORCEDDU MARIE BERNICE
IPC: C12N15/82
Filed: 2001-10-10
Abstract: Disclosed are methods relating to the selection of transformed embryonic tissue of coniferous plants. In particular a method is described for regenerating genetically modified plants of pine of the genus Pinus selected from the group consisting of Southern yellow pines and hybrids. This comprises selecting transgenic embryonic pine cells using a selection medium comprising a selection agent and an agent that regulates differentiation of embryos from embryonic cells and regenerating genetically modified plants from the transgenic embryonic plant cells.
Patent NZ-526902-A (NZ)
Title: Fungicide mixtures based on amide compounds
Inventor: EICKEN KARL
IPC: A01N43/50
Filed: 2001-12-13
Abstract: A fungicidal mixture, comprising: (a) amide compounds of formula I; and (b) imidazole derivatives of formula II; and a method for controlling harmful fungi, comprising treating the fungi or its habitat with the fungicidal mixture.
Patent NZ-527129-A (NZ)
Title: Polynucleotide constructs for increased lysine production
Inventor: LI LHING-YEW
IPC: C12N5/02
Filed: 2002-02-08
Abstract: An isolated polynucleotide molecule comprises a nucleic acid molecule encoding an aspartate kinase (ask) polypeptide; (b) a nucleic acid molecule encoding an aspartate-semialdehyde dehyrdogenase (asd) polypeptide; and (c) a nucleic aid molecule encoding a dihydrodipicolinate reductase (dapB) polypeptide. Also described are vectors, isolated cell and methods of producing lysine by culturing the host cells.
Patent NZ-529090-A (NZ)
Title: An improved rock breaking device
Inventor: ROBSON ANGUS PETER
IPC: B21J7/06
Filed: 2003-10-21
Abstract: A drop hammer assembly (4) including a hammer (1) configured with at least two end conditions (5, 6) characterized in that the position of the end conditions (5, 6) can be reversed when required, by withdrawing the hammer (1) from the housing (2), reversing the direction of the hammer (1) and reinserting the hammer (1) into its operating position.
Patent NZ-533019-A (NZ)
Title: Evaporator, typically for milk, with rotor having shallow cone pairs , and with vapour compressed and returned to a steam side of evaporator
Inventor: JEBSON RICHARD SELWYN
Filed: 2002-10-25
Abstract: An evaporator is stated to be particularly useful for milk evaporation. The evaporator includes a rotor 12 within steam chamber 11 of housing 10. Liquid feed passes through conduit 13 to emit through outlets 14 and 15 onto the inner periphery of evaporator surfaces 16 and 17 of cone pairs C, C1 and C2 (being part of the rotor 12). Concentrate can flow between cone pairs via tubes 22 at the other periphery of the cone pairs. Concentrate is picked up at cone pair C2 and the lowermost cone pair C1 to flow through outlet conduit 30. The surface angle of each cone is between 5 and 20o from a direction transverse to the axis of rotation of the rotor.
Patent NZ-533666-A (NZ)
Title: Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
Inventor: COLE DEREK CECIL
IPC: A61P25/18
Filed: 2002-12-17
Abstract: Disclosed are compounds of formula I, wherein; Q is SO2, CO, CONR9 or CSNR10, N is 2 or 3, R1 and R2 are independently H, halogen, CN, OCO2R12, CO2R13, CONR14R15, CNR16NR17R18, SOmR19, NR20R21, OR22, COR23 or alkyl, alkenyl, alkynyl, cycloalkyl, cycloheteroalkyl, aryl or heteroaryl, each optionally substituted, R3 and R4 are independently H or alkyl, R5 and R6 are independently H or alkyl, alkenyl, alkynyl, cycloalkyl, cycloheteroalkyl, aryl or heteroaryl, each optionally substituted, or R5 and R6 are taken together to form an optionally substituted 5- to 7-membered ring optionally containing an additional heteroatom, R7 is H, halogen or alkyl, alkoxy, aryl or heteroaryl, each optionally substituted, R8 is an optionally substituted bicyclic or tri-cyclic ring system having a N atom at a bridgehead and optionally additional heteroatoms. The compounds are used in the manufacture of medicaments for the treatment of disorders of the central nervous system related to or affected by the 5-HT6 receptor.